Literature DB >> 14247356

THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.

V VONKA, Z JANDA, J SIMON.   

Abstract

Entities:  

Keywords:  EXPERIMENTAL LAB STUDY; KIDNEY; MONKEYS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; VIRULENCE; VIRUS CULTIVATION

Mesh：

Substances：

Year:  1964        PMID： 14247356     DOI： 10.1007/bf01555117

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  11 in total

1.  STRAIN SPECIFICITY OF TYPE 1 NEUTRALIZING ANTIBODIES DEVELOPING IN CHILDREN FED WITH TYPE 1 SABIN'S ATTENUATED VIRUS (LSC 2AB).

Authors:  V VONKA; M TARABCAK; Z JANDA
Journal:  Arch Gesamte Virusforsch       Date:  1964

2.  Magnesium chloride enhancement of cell susceptibility to poliovirus.

Authors:  C WALLIS; J L MELNICK
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

3.  The stability of the intratypic antigenic character of Sabin's type 1 attenuated virus (LSc-2ab).

Authors:  V VONKA; Z JANDA; J SIMON
Journal:  Arch Gesamte Virusforsch       Date:  1962

4.  Is there an exceedingly small risk associated with oral poliovirus vaccine?

Authors:  A B SABIN
Journal:  JAMA       Date:  1963-01-26       Impact factor: 56.272

5.  Selection of attenuated poliovirus from virulent suspensions by heating in aluminum chloride.

Authors:  C WALLIS; J L MELNICK
Journal:  Virology       Date:  1963-04       Impact factor: 3.616

6.  [Poliomyelitis antibody development in adults after vaccination with Lederle triple vaccine of Sabin strains].

Authors:  O GSELL; E WIESMANN
Journal:  Schweiz Med Wochenschr       Date:  1962-04-21

7.  Antibody response to two different live poliomyelitis virus vaccines.

Authors:  J HOTCHIN; H PLAGER; W DECHER; J JACOBS
Journal:  N Y State J Med       Date:  1962-06-01

8.  Characteristics and genetic potentialities of experimentally produced and naturally occurring variants of poliomyelitis virus.

Authors:  A B SABIN
Journal:  Ann N Y Acad Sci       Date:  1955-09-27       Impact factor: 5.691

9.  Mass immunization with Sabin and Cox oral poliomyelitis vaccines. Experience in Monroe and Tompkins Counties, New York, 1960.

Authors:  M L RATHBUN; R H BROAD; W FONT; S MILHAM; W R AMES
Journal:  N Y State J Med       Date:  1962-06-01

10.  Experience with preparation an laboratory control of oral poliomyelitis vaccine in Czechoslovakia.

Authors:  D SLONIM; I MARES; M DREVO; H STURMOVA; J SIMON
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408
View more
  7 in total

1.  PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. 3. A SMALL SCALE TRIAL WITH USOL-D BAC VIRUS IN A CLOSED CHILD COMMUNITY.

Authors:  V VONKA; Z JANDA; J SIMON; E ADAM; H ZAVADOVA; M STAREK
Journal:  Arch Gesamte Virusforsch       Date:  1965

2.  PROPERTIES OF A NEW ATTENUATED TYPE 3 POLIOVIRUS. II. NEUROVIRULENCE TESTS ON MONKEYS.

Authors:  J SIMON
Journal:  Arch Gesamte Virusforsch       Date:  1965

3.  Investigation of type 3 poliovirus variants with increased L-cystine-dependence as live vaccines.

Authors:  L B Elbert; M P Chumakov; G L Krutyanskaya; N M Ralph; A V Tyufanov; I S Sokolova; G A Alpatova
Journal:  Arch Gesamte Virusforsch       Date:  1971

4.  Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus.

Authors:  Z Janda; E Adam; V Vonka
Journal:  Arch Gesamte Virusforsch       Date:  1967

5.  Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract.

Authors:  J Simon; V Vonka; Z Janda
Journal:  Arch Gesamte Virusforsch       Date:  1965

6.  [Neurovirulence of a new attenuated poliovirus type 3 (USOL-D) in a monkey experiment].

Authors:  F Unterharnscheidt; J Simon
Journal:  Naturwissenschaften       Date:  1965-09

7.  USOL-D bac (type 3 poliovirus) vaccine studies.

Authors: 
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.